The new LQB-223 compound modulates ERK1/ERK2 MAP kinase pathway, and microRNA-7, in glioblastoma cell lines exhibiting different radioresistance profiles.
CLINICAL CANCER RESEARCH(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
CLINICAL CANCER RESEARCH(2018)